Abstract:Our study suggests that exome sequencing adds approximately 60% of the diagnostic yield in fetuses with skeletal abnormalities reported in previous literature. The dysplasia phenotypes had a higher incremental yield, whereas the dysostoses group according to this study had a relatively lower yield, especially in the isolated dysostoses group. Such differences may result from pathogenic mechanisms. Identifying these phenotypes is important for diagnosis, prognosis, and clinical consultation. Introduction Fetal skeletal abnormalities can be caused by various factors and genetic cause plays an important role. Prenatal exome sequencing (ES) has been shown to be a powerful approach for accurate prenatal molecular diagnoses. Diagnostic yield of ES in fetal skeletal abnormalities varies significantly across studies. This study aimed to perform a systematic review of the literature and meta‐analysis to assess the incremental yield of ES in fetuses with different kinds of skeletal abnormalities and a negative result on chromosome microarray or karyotyping. Material and Methods The PubMed, Embase, Web of Science, and Cochrane Library databases were systematically searched up to November 26, 2022. Relevant data were collected from observational studies containing five or more cases of skeletal abnormalities who underwent ES. The incremental yield of ES was evaluated by single proportion analysis and 95% confidence interval (CI), both according to the article features and individual phenotypes. This study was registered on PROSPERO as CRD42022382800. Results Twenty‐six studies including 524 individuals met the inclusion criteria. The pooled incremental yield was 60.2% (95% CI, 53.4%–66.9%) for all fetuses with skeletal abnormalities. In subgroup analysis, the additional diagnostic yield was 83.9% (95% CI, 76.4%–90.4%) in isolated dysplasia cases (group I), 52.0% (95% CI, 32.9%–70.9%) in dysplasia with non‐skeletal abnormalities cases (group II), 33.3% (95% CI, 19.3%–48.6%) in isolate dysostoses cases (group III), 47.8% (95 % CI, 35.8%–60.0%) in dysostoses with non‐skeletal abnormalities cases (group IV), 83.0% (95% CI, 63.7%–97.1%) in combination of the two phenotypes without non‐skeletal abnormalities cases (group V), 74.5% (95% CI, 54.9%–90.9%) in combination of the two phenotypes with non‐skeletal abnormalities cases (group VI). The origin of the pathogenic variations differed among the groups. Most causative variants were de novo in groups I (97/133, 72.9%), V (14/23, 60.9%), and VI (15/26, 57.7%). Meanwhile, pathogenic variations in III (18/25, 72.0%) and IV (37/67, 55.2%) were more often inherited from a parent. Conclusions ES had a favorable incremental yield in fetuses with skeletal abnormalities. The common pathogenic variations and genetic patterns of skeletal abnormalities vary among different subtypes. Interpreting this difference is beneficial for personalized clinical consultation.

Prenatal exome sequencing for morphologically normal fetus: Should we be doing it?

Exome sequencing in every pregnancy? Results of trio exome sequencing in structurally normal fetuses

Whole exome sequencing as a diagnostic adjunct to clinical testing in fetuses with structural abnormalities

Prenatal Trio-Based Whole Exome Sequencing in Fetuses with Abnormalities of the Skeletal System

Prenatal exome sequencing in fetuses with callosal anomalies

Application of exome sequencing for prenatal diagnosis of fetal structural anomalies: clinical experience and lessons learned from a cohort of 1618 fetuses

Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta‐analysis

Prenatal Genome-Wide Sequencing analysis (Exome or Genome) in detecting pathogenic Single Nucleotide Variants in fetal Central Nervous System Anomalies: systematic review and meta-analysis

Exome sequencing in fetuses with short long bones detected by ultrasonography: A retrospective cohort study

Trio-whole exome sequencing and preimplantation genetic diagnosis for unexplained recurrent fetal malformations.

Exome sequencing improves genetic diagnosis of fetal increased nuchal translucency

Promises, pitfalls and practicalities of prenatal whole exome sequencing

Incremental yield of prenatal exome sequencing in fetuses with skeletal system abnormalities: A systematic review and meta‐analysis

Prenatal diagnosis of fetuses with ultrasound anomalies by whole-exome sequencing in Luoyang city, China

The High Diagnostic Yield of Prenatal Exome Sequencing Followed by 3400 Gene Panel Analysis in 629 Ongoing Pregnancies With Ultrasound Anomalies

Prospective Prenatal Cell-Free DNA Screening for Genetic Conditions of Heterogenous Etiologies

Combined Exome Sequencing and Deep Phenotyping in Highly Selected Fetuses with Skeletal Dysplasia During the First and Second Trimesters Improves Diagnostic Yield

Prenatal diagnosis of fetal skeletal anomalies via whole-exome sequencing in a tertiary referral center

Exome sequencing in fetuses with congenital diaphragmatic hernia in a nationwide cohort

Novel and recurrent variants identified in fetuses with central nervous system abnormalities by trios-medical exome sequencing

Noninvasive fetal genotyping of single nucleotide variants and linkage analysis for prenatal diagnosis of monogenic disorders